Stokes Capital Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Stokes Capital Advisors, LLC holds 10 biotech & pharma companies tracked by BioSniper, totaling $65.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$65.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 83,418 | $20.4M |
| ABBVAbbVie Inc. | 73,676 | $16.0M |
| LLYELI LILLY & Co | 12,572 | $11.6M |
| ABTABBOTT LABORATORIES | 112,046 | $11.5M |
| AMGNAMGEN INC | 4,612 | $1.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,368 | $1.5M |
| MRKMerck & Co., Inc. | 8,196 | $986K |
| PFEPFIZER INC | 33,250 | $934K |
| NVONovo Nordisk A/S | 17,200 | $632K |
| GILDGILEAD SCIENCES, INC. | 4,050 | $564K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.